Recombinant Human ACSL1 Protein，His

ACSL1, or acyl-CoA synthetase long-chain family member 1, plays a critical role in fatty acid metabolism and is involved in the activation of long-chain fatty acids to form acyl-CoA derivatives. Its significance extends beyond metabolism, as it has been implicated in various physiological processes, including membrane lipid synthesis, energy homeostasis, and signaling pathways. Dysregulation of ACSL1 has been associated with metabolic disorders, cancer, and cardiovascular diseases, making it a target of considerable interest in biomedical research. The recombinant expression of ACSL1 allows for the detailed study of its enzymatic activity and regulatory mechanisms, facilitating the understanding of its role in lipid metabolism and its contributions to disease pathogenesis. By producing recombinant ACSL1, researchers can investigate the protein's structure-function relationships, determine its specific substrate preferences, and explore its interactions with other metabolic pathways. This knowledge is vital for developing therapeutic strategies aimed at modulating ACSL1 activity in disease contexts, thereby providing insights into potential interventions for metabolic syndrome, obesity, and related disorders. Additionally, studies on ACSL1 can contribute to the broader understanding of lipid homeostasis and its implications in health and disease.